Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Recruiting Observational Study
Diabetes Cholesterol Cancer Blood Pressure Disorders Heart Disease Respiratory Ilness COPD Adverse Drug Reaction (ADR) Poly Pharmacy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
Texas A&M University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This program collects genetic and health information to help doctors choose the right medications for patients.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * The study will invite patients who are eligible for PGX workup/PGX care to participate, provided they meet the following criteria: Use of five or more medications, including over the counter drugs, supplements, natural products, cannabis products, or other recreational drugs, …
Contacts

Kenneth S Ramos, MD, PhD

(713) 677-7440

kramos@tamu.edu

CONTACT

Rick Silva, PhD

ricksilva@tamu.edu

CONTACT